Versant Capital Management Inc Boosts Stock Holdings in Colgate-Palmolive (NYSE:CL)

Versant Capital Management Inc lifted its stake in Colgate-Palmolive (NYSE:CL) by 32.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,881 shares of the company’s stock after purchasing an additional 465 shares during the period. Versant Capital Management Inc’s holdings in Colgate-Palmolive were worth $171,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Old Port Advisors increased its position in shares of Colgate-Palmolive by 7.0% in the 4th quarter. Old Port Advisors now owns 2,589 shares of the company’s stock valued at $235,000 after purchasing an additional 170 shares during the last quarter. Principal Financial Group Inc. increased its holdings in Colgate-Palmolive by 4.9% in the third quarter. Principal Financial Group Inc. now owns 997,147 shares of the company’s stock valued at $103,514,000 after buying an additional 46,944 shares during the last quarter. DGS Capital Management LLC raised its stake in Colgate-Palmolive by 35.9% in the third quarter. DGS Capital Management LLC now owns 8,625 shares of the company’s stock valued at $895,000 after buying an additional 2,280 shares in the last quarter. Garde Capital Inc. lifted its holdings in Colgate-Palmolive by 19.5% during the 3rd quarter. Garde Capital Inc. now owns 1,553 shares of the company’s stock worth $161,000 after buying an additional 253 shares during the last quarter. Finally, Peapack Gladstone Financial Corp boosted its position in shares of Colgate-Palmolive by 2.4% during the 3rd quarter. Peapack Gladstone Financial Corp now owns 50,653 shares of the company’s stock worth $5,258,000 after acquiring an additional 1,203 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Down 0.4 %

Colgate-Palmolive stock opened at $90.15 on Friday. The stock’s 50 day moving average price is $93.46 and its 200 day moving average price is $98.46. Colgate-Palmolive has a 1-year low of $79.52 and a 1-year high of $109.30. The company has a market cap of $73.65 billion, a PE ratio of 25.83, a price-to-earnings-growth ratio of 3.31 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.22%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and upped their price target for the company from $107.00 to $109.00 in a report on Monday, September 9th. TD Cowen dropped their target price on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Stifel Nicolaus cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and reduced their price target for the company from $105.00 to $101.00 in a research report on Monday, October 28th. JPMorgan Chase & Co. raised their price objective on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Finally, Piper Sandler assumed coverage on Colgate-Palmolive in a report on Tuesday, September 24th. They issued an “overweight” rating and a $121.00 target price for the company. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive currently has an average rating of “Moderate Buy” and a consensus price target of $105.11.

Insider Activity

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This represents a 55.29 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 0.34% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.